Cargando…

Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia

Critically ill patients with COVID-19 pneumonia suffered both high thrombotic and bleeding risk. The effect of SARS-CoV-2 on coagulation and fibrinolysis is not well known. We conducted a retrospective study of critically ill patients admitted to an intensive care unit (ICU) a cause of severe COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavoni, Vittorio, Gianesello, Lara, Pazzi, Maddalena, Stera, Caterina, Meconi, Tommaso, Frigieri, Francesca Covani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211560/
https://www.ncbi.nlm.nih.gov/pubmed/32394236
http://dx.doi.org/10.1007/s11239-020-02130-7
_version_ 1783531464519843840
author Pavoni, Vittorio
Gianesello, Lara
Pazzi, Maddalena
Stera, Caterina
Meconi, Tommaso
Frigieri, Francesca Covani
author_facet Pavoni, Vittorio
Gianesello, Lara
Pazzi, Maddalena
Stera, Caterina
Meconi, Tommaso
Frigieri, Francesca Covani
author_sort Pavoni, Vittorio
collection PubMed
description Critically ill patients with COVID-19 pneumonia suffered both high thrombotic and bleeding risk. The effect of SARS-CoV-2 on coagulation and fibrinolysis is not well known. We conducted a retrospective study of critically ill patients admitted to an intensive care unit (ICU) a cause of severe COVID-19 pneumonia and we evaluated coagulation function using rotational thromboelastometry (ROTEM) on day of admission (T0) and 5 (T5) and 10 (T10) days after admission to ICU. Coagulation standard parameters were also evaluated. Forty patients were enrolled into the study. The ICU and the hospital mortality were 10% and 12.5%, respectively. On ICU admission, prothrombin time was slightly reduced and it increased significantly at T10 (T0 = 65.1 ± 9.8 vs T10 = 85.7 ± 1.5, p = 0.002), while activated partial thromboplastin time and fibrinogen values were higher at T0 than T10 (32.2 ± 2.9 vs 27.2 ± 2.1, p = 0.017 and 895.1 ± 110 vs 332.5 ± 50, p = 0.002, respectively); moreover, whole blood thromboelastometry profiles were consistent with hypercoagulability characterized by an acceleration of the propagation phase of blood clot formation [i.e., CFT below the lower limit in INTEM 16/40 patients (40%) and EXTEM 20/40 patients (50%)] and significant higher clot strength [MCF above the upper limit in INTEM 20/40 patients (50%), in EXTEM 28/40 patients (70%) and in FIBTEM 29/40 patients (72.5%)]; however, this hypercoagulable state persists in the first five days, but it decreases ten day after, without returning to normal values. No sign of secondary hyperfibrinolysis or sepsis induced coagulopathy (SIC) were found during the study period. In six patients (15%) a deep vein thrombosis and in 2 patients (5%) a thromboembolic event, were found; 12 patients (30%) had a catheter-related thrombosis. ROTEM analysis confirms that patients with severe COVID-19 pneumonia had a hypercoagulation state that persisted over time.
format Online
Article
Text
id pubmed-7211560
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-72115602020-05-11 Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia Pavoni, Vittorio Gianesello, Lara Pazzi, Maddalena Stera, Caterina Meconi, Tommaso Frigieri, Francesca Covani J Thromb Thrombolysis Article Critically ill patients with COVID-19 pneumonia suffered both high thrombotic and bleeding risk. The effect of SARS-CoV-2 on coagulation and fibrinolysis is not well known. We conducted a retrospective study of critically ill patients admitted to an intensive care unit (ICU) a cause of severe COVID-19 pneumonia and we evaluated coagulation function using rotational thromboelastometry (ROTEM) on day of admission (T0) and 5 (T5) and 10 (T10) days after admission to ICU. Coagulation standard parameters were also evaluated. Forty patients were enrolled into the study. The ICU and the hospital mortality were 10% and 12.5%, respectively. On ICU admission, prothrombin time was slightly reduced and it increased significantly at T10 (T0 = 65.1 ± 9.8 vs T10 = 85.7 ± 1.5, p = 0.002), while activated partial thromboplastin time and fibrinogen values were higher at T0 than T10 (32.2 ± 2.9 vs 27.2 ± 2.1, p = 0.017 and 895.1 ± 110 vs 332.5 ± 50, p = 0.002, respectively); moreover, whole blood thromboelastometry profiles were consistent with hypercoagulability characterized by an acceleration of the propagation phase of blood clot formation [i.e., CFT below the lower limit in INTEM 16/40 patients (40%) and EXTEM 20/40 patients (50%)] and significant higher clot strength [MCF above the upper limit in INTEM 20/40 patients (50%), in EXTEM 28/40 patients (70%) and in FIBTEM 29/40 patients (72.5%)]; however, this hypercoagulable state persists in the first five days, but it decreases ten day after, without returning to normal values. No sign of secondary hyperfibrinolysis or sepsis induced coagulopathy (SIC) were found during the study period. In six patients (15%) a deep vein thrombosis and in 2 patients (5%) a thromboembolic event, were found; 12 patients (30%) had a catheter-related thrombosis. ROTEM analysis confirms that patients with severe COVID-19 pneumonia had a hypercoagulation state that persisted over time. Springer US 2020-05-11 2020 /pmc/articles/PMC7211560/ /pubmed/32394236 http://dx.doi.org/10.1007/s11239-020-02130-7 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Pavoni, Vittorio
Gianesello, Lara
Pazzi, Maddalena
Stera, Caterina
Meconi, Tommaso
Frigieri, Francesca Covani
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
title Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
title_full Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
title_fullStr Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
title_full_unstemmed Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
title_short Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
title_sort evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe covid-19 pneumonia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211560/
https://www.ncbi.nlm.nih.gov/pubmed/32394236
http://dx.doi.org/10.1007/s11239-020-02130-7
work_keys_str_mv AT pavonivittorio evaluationofcoagulationfunctionbyrotationthromboelastometryincriticallyillpatientswithseverecovid19pneumonia
AT gianesellolara evaluationofcoagulationfunctionbyrotationthromboelastometryincriticallyillpatientswithseverecovid19pneumonia
AT pazzimaddalena evaluationofcoagulationfunctionbyrotationthromboelastometryincriticallyillpatientswithseverecovid19pneumonia
AT steracaterina evaluationofcoagulationfunctionbyrotationthromboelastometryincriticallyillpatientswithseverecovid19pneumonia
AT meconitommaso evaluationofcoagulationfunctionbyrotationthromboelastometryincriticallyillpatientswithseverecovid19pneumonia
AT frigierifrancescacovani evaluationofcoagulationfunctionbyrotationthromboelastometryincriticallyillpatientswithseverecovid19pneumonia